PLASMAFLO OP OP-05W(A) N/A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2018-08-22 for PLASMAFLO OP OP-05W(A) N/A manufactured by Asahi Kasei Medical Co., Ltd..

Event Text Entries

[117836228] The product in complaint was not returned to the manufacturer and could not be analyzed. The lot number in complaint was not reported and we could not review the manufacturing and quality control records. According to physician's comment, the patient was treated with the anticoagulant for her first time, so the relationship between anticoagulant and the event of "blood pressure decreased" cannot be ruled out, but as after definite period of time from the start of the treatment the patient developed "blood pressure decreased", so the causal relationship of adsorption column to the event is very likely. We decided to submit this case because the causal relationship between this event and the plasmaflo op could not be denied however the physician considers the causal relationship between this event and immusorba tr350 cannot be ruled out. "blood pressure decreased" is written in the package insert as the event ("hypotonia") to monitor during the treatment. This ae might have occurred in part or in total related to the patient's physiology. Plasmaflo op is used as plasma separator and immusorba tr-350 is used for immunoadsorption column for separated plasma. This incident occurred in (b)(6) and is reported to fda according to the requirement.
Patient Sequence No: 1, Text Type: N, H10


[117836229] The female patient experienced the following adverse event in (b)(6). The female patient, whose blood pressure was 110mmhg, was started the treatment of the immunoadsorption plasmapheresis (iapp) with the plasma separator (plasmaflo op-05w), which was a similar product of plasmaflo op-05w(a) sold in u. S. After 75 minutes the treatment started, her blood pressure (bp) decreased to 40 mmhg rapidly. She was given the treatment of elevation of lower extremities and with the normal saline solution 500ml intravenously, and was given oxygen 4l. After 30 minutes, she was started with the treatment of the normal saline solution intravenously by her blood access. After 15 minutes her blood pressure recovered to 100mmhg, she went back to her hospital ward. This was her first time for her treatment of iapp, but after this event she was not given such treatment.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8010002-2018-00170
MDR Report Key7804167
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2018-08-22
Date of Report2018-07-27
Date of Event2018-06-28
Date Mfgr Received2018-07-27
Date Added to Maude2018-08-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. AKITAKE YAMASHITA
Manufacturer Street1-1-2 YURAKUCHO, CHIYODA-KU
Manufacturer CityTOKYO 100-0006
Manufacturer CountryJA
Manufacturer Postal100-0006
Manufacturer G1ASAHI KASEI MEDICAL MT CORP.
Manufacturer StreetOITA WORKS 2111-2 OAZA SATO
Manufacturer CityOITA-SHI, OITA 870-0396
Manufacturer CountryJA
Manufacturer Postal Code870-0396
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePLASMAFLO OP
Generic NamePLASMA SEPARATOR
Product CodeMDP
Date Received2018-08-22
Model NumberOP-05W(A)
Catalog NumberN/A
Lot NumberN/A
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerASAHI KASEI MEDICAL CO., LTD.
Manufacturer Address1-1-2 YURAKUCHO CHIYODA-KU TOKYO 100-0006 JA 100-0006


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-08-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.